MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of Ga-68-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients

Gruber, Leonhard; Jimenez-Franco, Luis David; Decristoforo, Clemens; Uprimny, Christian; Glatting, Gerhard; Hohenberger, Peter; Schoenberg, Stefan O.; Reindl, Wolfgang; Orlandi, Francesca; Mariani, Maurizio; Jaschke, Werner; Virgolini, Irene

Erstveröffentlichung

2020

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Gruber, Leonhard

Jimenez-Franco, Luis David

Decristoforo, Clemens

Uprimny, Christian

Glatting, Gerhard

et al.

Institutions

UKU. Klinik für Nuklearmedizin

Published in

Journal of Nuclear Medicine ; 61 (2020), 12. - S. 1749-1755. - ISSN 0161-5505. - eISSN 1535-5667

Link to publication

https://dx.doi.org/10.2967/jnumed.119.238808

Keywords

GIST; PET; Ga-68-NeoBOMB1; GRPR; Phase I/IIa study; GASTROINTESTINAL STROMAL TUMORS; POSITRON-EMISSION-TOMOGRAPHY; PROSTATE-CANCER PATIENTS; RADIATION-DOSIMETRY; ADJUVANT IMATINIB; BOMBESIN ANALOG; EXPRESSION; AGONISTS

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record